Literature DB >> 20536559

Orphan granzymes find a home.

Niels Bovenschen1, J Alain Kummer.   

Abstract

Cytotoxic lymphocytes are armed with granules that are released in the granule-exocytosis pathway to kill tumor cells and virus-infected cells. Cytotoxic granules contain the pore-forming protein perforin and a family of structurally homologues serine proteases called granzymes. While perforin facilitates the entry of granzymes into a target cell, the latter initiate distinct apoptotic routes. Granzymes are also implicated in extracellular functions such as extracellular matrix degradation, immune regulation, and inflammation. The family of human granzymes consists of five members, of which granzyme A and B have been studied most extensively. Recently, elucidation of the specific characteristics of the other three human granzymes H, K, and M, also referred to as orphan granzymes, have started. In this review, we summarize and discuss what is currently known about the biology of the human orphan granzymes.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20536559     DOI: 10.1111/j.0105-2896.2010.00889.x

Source DB:  PubMed          Journal:  Immunol Rev        ISSN: 0105-2896            Impact factor:   12.988


  35 in total

Review 1.  T Cells and Regulated Cell Death: Kill or Be Killed.

Authors:  Johan Spetz; Adam G Presser; Kristopher A Sarosiek
Journal:  Int Rev Cell Mol Biol       Date:  2018-08-29       Impact factor: 6.813

2.  Granzyme K-deficient mice show no evidence of impaired antiviral immunity.

Authors:  Lars T Joeckel; Cody C Allison; Marc Pellegrini; Catherina H Bird; Phillip I Bird
Journal:  Immunol Cell Biol       Date:  2017-04-21       Impact factor: 5.126

Review 3.  Granzyme M: behind enemy lines.

Authors:  S A H de Poot; N Bovenschen
Journal:  Cell Death Differ       Date:  2014-01-10       Impact factor: 15.828

4.  Granzyme K inhibits replication of influenza virus through cleaving the nuclear transport complex importin α1/β dimer of infected host cells.

Authors:  C Zhong; C Li; X Wang; T Toyoda; G Gao; Z Fan
Journal:  Cell Death Differ       Date:  2011-12-02       Impact factor: 15.828

5.  A High Yield and Cost-efficient Expression System of Human Granzymes in Mammalian Cells.

Authors:  Farokh Dotiwala; Isabelle Fellay; Luis Filgueira; Denis Martinvalet; Judy Lieberman; Michael Walch
Journal:  J Vis Exp       Date:  2015-06-10       Impact factor: 1.355

6.  Granzyme K synergistically potentiates LPS-induced cytokine responses in human monocytes.

Authors:  Annette C Wensink; Vera Kemp; Job Fermie; M Isabel García Laorden; Tom van der Poll; C Erik Hack; Niels Bovenschen
Journal:  Proc Natl Acad Sci U S A       Date:  2014-04-07       Impact factor: 11.205

7.  Cleavage of Notch1 by granzyme B disables its transcriptional activity.

Authors:  Geert van Tetering; Niels Bovenschen; Jan Meeldijk; Paul J van Diest; Marc Vooijs
Journal:  Biochem J       Date:  2011-07-15       Impact factor: 3.857

8.  Infection history determines the differentiation state of human CD8+ T cells.

Authors:  Michiel C van Aalderen; Ester B M Remmerswaal; Niels J M Verstegen; Pleun Hombrink; Anja ten Brinke; Hanspeter Pircher; Neeltje A Kootstra; Ineke J M ten Berge; René A W van Lier
Journal:  J Virol       Date:  2015-02-25       Impact factor: 5.103

9.  Granzyme M targets host cell hnRNP K that is essential for human cytomegalovirus replication.

Authors:  R van Domselaar; S A H de Poot; E B M Remmerswaal; K W Lai; I J M ten Berge; N Bovenschen
Journal:  Cell Death Differ       Date:  2012-10-26       Impact factor: 15.828

10.  All human granzymes target hnRNP K that is essential for tumor cell viability.

Authors:  Robert van Domselaar; Razi Quadir; Astrid M van der Made; Roel Broekhuizen; Niels Bovenschen
Journal:  J Biol Chem       Date:  2012-05-11       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.